Finance

Lists
Why is 301075 up 3,45%?
Dive Deeper
301075:SHE
Tibet Duo Rui Pharmaceutical Co Ltd
56,30 CN¥
+3,45%
(+1,88) 1D
16-окт., 11:55:16 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301075...
Open
54,66 CN¥
High
56,85 CN¥
Low
54,66 CN¥
Mkt. cap
4,67 млд
Avg. vol.
1,12 млн
Volume
477,67 миң
52-wk high
98,29 CN¥
52-wk low
44,55 CN¥
EPS
-0,62 CN¥
Shares outstanding
80,00 млн
No. of employees
461
Open
54,66 CN¥
High
56,85 CN¥
Low
54,66 CN¥
Mkt. cap
4,67 млд
Avg. vol.
1,12 млн
Volume
477,67 миң
52-wk high
98,29 CN¥
52-wk low
44,55 CN¥
EPS
-0,62 CN¥
Shares outstanding
80,00 млн
No. of employees
461
News stories
From web sources and news partners
About Tibet Duo Rui Pharmaceutical Co Ltd
CEO-
Employees461
Founded2005
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
30,43 млн
17,18 млн
32,43 млн
63,22 млн
Cost of goods sold
32,04 млн
16,74 млн
29,99 млн
55,51 млн
Cost of revenue
32,04 млн
16,74 млн
29,99 млн
55,51 млн
Research and development expenses
20,93 млн
-8,19 млн
4,94 млн
8,48 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
16,76 млн
22,19 млн
15,08 млн
15,52 млн
Operating expense
47,89 млн
12,94 млн
17,03 млн
25,10 млн
Total operating expenses
79,93 млн
29,68 млн
47,01 млн
80,61 млн
Operating income
-49,50 млн
-12,51 млн
-14,58 млн
-17,38 млн
Other non operating income
-869,13 миң
-2,55 млн
-34,06 миң
-195,80 миң
EBT including unusual items
-52,43 млн
-20,21 млн
-18,95 млн
25,20 млн
EBT excluding unusual items
-54,28 млн
-19,39 млн
-17,93 млн
19,35 млн
Income tax expense
413,36 миң
-503,13 миң
62,27 миң
2,94 млн
Effective tax rate
-0,79%
2,49%
-0,33%
11,69%
Other operating expenses
1,76 млн
88,27 миң
-1,24 млн
2,31 млн
Net income
-37,22 млн
-22,44 млн
-13,97 млн
25,50 млн
Net profit margin
-122,35%
-130,64%
-43,07%
40,33%
Earnings per share
-
-
-
-
Interest and investment income
-
455,41 миң
18,98 миң
40,22 млн
Interest expense
-3,91 млн
-4,79 млн
-3,34 млн
-3,27 млн
Net interest expenses
-3,91 млн
-4,33 млн
-3,32 млн
36,95 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-42,82 млн
-296,34 миң
-2,37 млн
-4,81 млн
Gain or loss from assets sale
-9,56 миң
105,45 миң
-
-242,76 миң
AI content may include mistakes. Learn more
Google колдонмолору